HDAC8 and nonpapillary renal cell carcinoma: The observation that TKI treatment increased the expression of HDAC8 in ccRCC cells could explain why the antitumor effect of the combination of HDAC8 inhibitor and sunitinib treatment was attenuated after 13 days of xenograft growth (Figure 1).